30 April 2020

Recalls of Pharmaceutical Products & Medical Devices

Reference: CIR-2019-00000308

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Recall medical device Hudson RCI “ Sheridan” Endotracheal Tubes
• Recall of pharmaceutical product Benzoyl Peroxide Gel 2.5%
• Recall of pharmaceutical product Dimercaprol Injection IP B.A.L
• Recall one batch for pharmaceutical product Genticyn 80mg “Gentamycin” injection
• Recall one batch of infant formula milk Parent’s Choice Advantage Infant Formula Milk-Based Powder with Iron
• Recall two batch for pharmaceutical product Fluorouracil 5g-100ml Injection
• Voluntary recall from manufacturer of pharmaceutical products

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Voluntary recall from manufacturer of pharmaceutical products.pdf:

View Document

Recall two batch for pharmaceutical product Fluorouracil 5g-100ml Injection.pdf:

View Document

Recall one batch of infant formula milk Parents Choice Advantage Infant Formula Milk-Based Powder with Iron.pdf:

View Document

Recall one batch for pharmaceutical product Genticyn 80mg -Gentamycin- injection.pdf:

View Document

Recall of pharmaceutical product Dimercaprol Injection IP B.A.L.pdf:

View Document

Recall of pharmaceutical product Benzoyl Peroxide Gel 2.5%.pdf:

View Document

Recall medical device Hudson RCI - Sheridan - Endotracheal Tubes.pdf:

View Document